Today: 16 May 2026
Browse Category

Artificial Intelligence 9 January 2026 - 10 January 2026

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Eli Lilly shares fell 2% to $1,063.56 Friday, extending a two-day decline and lagging the broader market. The drop followed late-stage trial results for a Zepbound-Taltz drug combo and news of a $1.2 billion deal to buy Ventyx Biosciences. A Form 4 filing showed Lilly Endowment sold 292,148 shares on January 7. Lilly will present at the J.P. Morgan Healthcare Conference on January 13.
Microsoft stock has a new AI-commerce catalyst as Copilot Checkout rolls out with PayPal

Microsoft stock has a new AI-commerce catalyst as Copilot Checkout rolls out with PayPal

Microsoft shares rose 0.2% to $479.28 Friday after the company launched Copilot Checkout and new “agentic AI” tools for retailers. PayPal will handle payments for the new platform. The S&P 500 closed at a record high, up 0.6%. U.S. CPI data is due Jan. 13, with Microsoft’s Q2 earnings set for Jan. 28.
SoundHound AI stock jumps 7% as Wall Street resets targets after CES demos

SoundHound AI stock jumps 7% as Wall Street resets targets after CES demos

SoundHound AI shares closed up 6.7% at $11.75 Friday, with 39.3 million shares traded after CES product demos and news of a TomTom partnership. DA Davidson cut its price target to $14, while Oppenheimer and Cantor Fitzgerald maintained their ratings. The stock finished below key moving averages. Investors await Tuesday’s U.S. CPI data and SoundHound’s next earnings report, estimated for Feb. 26.
Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Schrödinger will integrate Eli Lilly’s AI drug discovery platform, TuneLab, into its LiveDesign software, giving biotech teams direct access to Lilly’s predictive models. Revvity and Benchling also announced deals to offer TuneLab through their platforms. Lilly and Revvity will jointly fund access for select users, using federated learning to protect data. BigHat Biosciences will collaborate with Lilly to improve antibody developability models.
Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

Marvell Technology shares fell 0.3% to $83.22 Friday, extending their weekly loss to about 8%. SEC filings showed Chief Legal Officer Mark Casper sold 5,000 shares at $93.08 each. The drop follows Marvell’s $540 million deal to acquire XConn Technologies. Investors are watching for next week’s U.S. CPI report and Marvell’s earnings in early March.
Vistra stock jumps after Meta signs 20-year nuclear power deal to feed AI data centers

Vistra stock jumps after Meta signs 20-year nuclear power deal to feed AI data centers

Vistra shares jumped 10.5% after-hours as Meta signed 20-year power purchase agreements for over 2,600 MW from three Vistra nuclear plants in PJM, with deliveries starting in late 2026. An SEC filing showed Vistra expects the deals to boost its adjusted free cash flow by up to 17% once plant upgrades are complete by 2034.
Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Applied Digital shares rose 18% to $37.68 in after-hours trading Friday after reporting fiscal Q2 revenue of $126.6 million, beating estimates. The company announced new leases totaling 600 MW, including a $5 billion, 200 MW deal at its Polaris Forge 2 campus. Cash stood at $1.91 billion as of Nov. 30, with $2.59 billion in long-term debt. Net loss for the quarter was $19.1 million.
Meta stock edges higher after nuclear power deals aimed at AI data centers

Meta stock edges higher after nuclear power deals aimed at AI data centers

Meta shares rose 1.1% to $653.06 in after-hours trading Friday after announcing nuclear power deals to supply its AI data centers. Agreements with Vistra, Oklo, and TerraPower could support up to 6.6 gigawatts of nuclear capacity by 2035. Financial terms were not disclosed. Investors are watching project timelines and permitting.
Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft shares rose 0.2% to $479.07 Friday after launching a Copilot checkout tool and new “agentic AI” features for retailers. The company, now valued at $3.85 trillion, will report fiscal Q2 results after markets close Jan. 28. Wells Fargo cut its price target to $665 but kept an Overweight rating. Some new retail AI features remain in preview, with adoption by merchants still uncertain.
Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce shares slipped 0.2% to $260.01 after unveiling its Spring ’26 product release, featuring new AI and automation tools, set to roll out from Feb. 23. U.S. payrolls rose by 50,000 in December, below forecasts, while unemployment fell to 4.4%. The S&P 500 hit a record intraday high after the jobs report. Fed funds futures priced in a 4.8% chance of a rate cut at the next Fed meeting.
Accenture stock price today: ACN slips as jobs data resets rate bets, new retail AI push in focus

Accenture stock price today: ACN slips as jobs data resets rate bets, new retail AI push in focus

Accenture shares fell 0.6% to $280.15 Friday afternoon, trailing gains in the broader market after a weaker-than-expected U.S. jobs report. The company announced a new AI partnership with Profitmind and will demo the technology at the National Retail Federation event next week. Investors are watching for Accenture’s earnings call on March 19 and the Federal Reserve’s policy meeting Jan. 27-28.
Vistra stock jumps as Meta locks in 20-year nuclear power deal for AI data centers

Vistra stock jumps as Meta locks in 20-year nuclear power deal for AI data centers

Vistra shares rose 11% to $167.11 by midday Friday after Meta signed 20-year nuclear power purchase agreements for 2,609 MW, with deliveries starting in late 2026. The deals cover Vistra’s Perry, Davis-Besse, and Beaver Valley plants. Investors focused on capital spending for upgrades and license extensions. Meta aims to secure power for its Ohio data center and future AI operations.
IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN shares rose 4.6% to $47.76 Friday, trading between $45.52 and $49.99 in heavy volume. Bernstein analyst Gautam Chhugani named IREN his top AI pick for 2026, according to TipRanks. Investors are watching for February earnings and signs of capital needs tied to the company’s AI expansion. IREN operates renewable-powered data centers in Canada and Texas and signed a $9.7 billion AI cloud deal with Microsoft last year.
1 68 69 70 71 72 184

Stock Market Today

  • Tracking Berkshire Hathaway Portfolio: Insights and Disclosures
    May 16, 2026, 2:25 AM EDT. This article analyzes Berkshire Hathaway's portfolio through 13F filings, offering insights for DIY investors on exploiting market inefficiencies and momentum. The author holds long positions in key stocks like GOOGL, AMZN, and MA, disclosing no conflict of interest or compensation beyond Seeking Alpha. The piece cautions that past performance does not guarantee future results and does not constitute investment advice. It reflects personal opinions and is independent of Seeking Alpha's institutional views.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop